The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to The Trustees of Columbia University in New York to provide community engagement and development initiatives supporting FDA programs. Under the single award contract with a potential value of $10 million and period of performance through September 2025, Columbia University will serve as a convener organization facilitating collaboration between FDA staff and external stakeholders. Two delivery orders have been issued to date, the first for $3.6 million to support a community engagement initiative through September 2024, and the second for $1.1 million for a biosafety effectiveness and safety outreach effort through September 2021. Both orders utilize time and materials pricing and will be performed in New York. The original solicitation sought proposals for convening meetings and developing methods to evaluate product safety and effectiveness as part of FDA's ongoing efforts to modernize public health programs and communication with regulated communities. Columbia University will leverage its expertise in public health and outreach to deliver services enhancing FDA's dialogue on important regulatory issues.
Generated 1/5/24, 12:26 AM